These drugs mimic the hormone GLP-1, which stimulates insulin production and controls gastric emptying after food is consumed
It refers to the side effects of the rapid weight loss produced by any of the GLP-1 medications
Consistently under-eating can increase the risk of nutrient deficiencies, fatigue, and lean muscle loss
Furthermore, it was reported that this risk increases with the duration of exposure to GLP-1 receptor agonists, with the highest risk observed after 1.6 years
And if you're new to Ozempic or Wegovy, your first two months of treatment will cost just $199 per month
In fact, in each of these trials, excluding ELIXA, treatment with GLP-1RA was associated with a significant reduction in new-onset MA, which is a surrogate marker for CV and hard renal outcomes (Table 1) [11]